Dexamethasone and SARS-CoV-2: the Dangerous Steroids Pandemic (Letter to the Editorial Office)

1. WHO Coronavirus Disease (COVID-19) Dashboard, https://covid19.who.int. [accessed 4 August 2021].

2. RECOVERY Collaborative Group, Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., Elmahi E., Prudon B., Green C., Felton T., Chadwick D., Rege K., Fegan C., Chappell L.C., Faust S.N., Jaki T., Jeffery K., Montgomery A., Rowan K., Juszczak E., Baillie J.K., Haynes R., Landray M.J. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. 2020 Jul 17: NEJMoa2021436. DOI: 10.1056/NEJMoa2021436. Epub ahead of print. PMID: 32678530; PMCID: PMC7383595.

3. Baiardo Redaelli M., Belletti A., Monti G., Monti G., Lembo R., Ortalda A., Landoni G., Bellomo R. The impact of nonblinding in critical care medicine trials. J Crit Care. 2018; 48: 414–417. DOI: 10.1016/j.jcrc.2018.09.031.

4. Pasin L., Navalesi P., Zangrillo A., Kuzovlev A., Likhvantsev V., Hajjar L.A., Fresilli S., Lacerda M.V.G., Landoni G. Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials. J Cardiothorac Vasc Anesth. 2021; 35 (2): 578–584. DOI: 10.1053/j.jvca.2020.11.057. Epub 2020 Nov 28. PMID: 33298370. PMCID: PMC7698829.

5. Tabata S., Imai K., Kawano S., Ikeda M., Kodama T., Miyoshi K., Obinata H., Mimura S., Kodera T., Kitagaki M., Sato M., Suzuki S., Ito T., Uwabe Y., Tamura K. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis. Lancet Infect Dis. 2020; 20 (9): 1043–1050. DOI: 10.1016/S1473-3099(20)30482-5. Epub 2020 Jun 12. PMID: 32539988. PMCID: PMC7292609.

6. Alessi J., de Oliveira G.B., Schaan B.D., Telo G.H. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes. Diabetol Metab Syndr. 2020; 12: 80. DOI: 10.1186/s13098-020-00583-7. PMID: 32922517. PMCID: PMC7476640.